180 related articles for article (PubMed ID: 27879265)
1. IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer.
Wang L; Miyahira AK; Simons DL; Lu X; Chang AY; Wang C; Suni MA; Maino VC; Dirbas FM; Yim J; Waisman J; Lee PP
Cancer Res; 2017 Mar; 77(5):1119-1126. PubMed ID: 27879265
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood immune markers in breast cancer: Differences in regulatory T cell abundance are related to clinical parameters.
Jørgensen N; Lænkholm AV; Sækmose SG; Hansen LB; Hviid TVF
Clin Immunol; 2021 Nov; 232():108847. PubMed ID: 34506945
[TBL] [Abstract][Full Text] [Related]
3. Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer.
Farren MR; Mace TA; Geyer S; Mikhail S; Wu C; Ciombor K; Tahiri S; Ahn D; Noonan AM; Villalona-Calero M; Bekaii-Saab T; Lesinski GB
Clin Cancer Res; 2016 May; 22(10):2565-74. PubMed ID: 26719427
[TBL] [Abstract][Full Text] [Related]
4. An IL6-Adenosine Positive Feedback Loop between CD73
Hu G; Cheng P; Pan J; Wang S; Ding Q; Jiang Z; Cheng L; Shao X; Huang L; Huang J
Cancer Immunol Res; 2020 Oct; 8(10):1273-1286. PubMed ID: 32847938
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes.
Wang L; Simons DL; Lu X; Tu TY; Avalos C; Chang AY; Dirbas FM; Yim JH; Waisman J; Lee PP
EBioMedicine; 2020 Feb; 52():102631. PubMed ID: 31981982
[TBL] [Abstract][Full Text] [Related]
6. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H
Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259
[TBL] [Abstract][Full Text] [Related]
7. Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218.
Alvarez Secord A; Bell Burdett K; Owzar K; Tritchler D; Sibley AB; Liu Y; Starr MD; Brady JC; Lankes HA; Hurwitz HI; Mannel RS; Tewari KS; O'Malley DM; Gray H; Bakkum-Gamez JN; Fujiwara K; Boente M; Deng W; Burger RA; Birrer MJ; Nixon AB
Clin Cancer Res; 2020 Mar; 26(6):1288-1296. PubMed ID: 31919136
[TBL] [Abstract][Full Text] [Related]
8. Chikusetsusaponin IVa Butyl Ester (CS-IVa-Be), a Novel IL6R Antagonist, Inhibits IL6/STAT3 Signaling Pathway and Induces Cancer Cell Apoptosis.
Yang J; Qian S; Cai X; Lu W; Hu C; Sun X; Yang Y; Yu Q; Gao SP; Cao P
Mol Cancer Ther; 2016 Jun; 15(6):1190-200. PubMed ID: 26929249
[TBL] [Abstract][Full Text] [Related]
9. Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy.
Westbury CB; Haviland J; Davies S; Gothard L; Abdi BA; Sydenham M; Bowen J; Stratton R; Short SC; Yarnold JR
Radiat Oncol; 2014 Apr; 9():103. PubMed ID: 24885397
[TBL] [Abstract][Full Text] [Related]
10. Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers.
Høgdall D; O'Rourke CJ; Dehlendorff C; Larsen OF; Jensen LH; Johansen AZ; Dang H; Factor VM; Grunnet M; Mau-Sørensen M; Oliveira DVNP; Linnemann D; Boisen MK; Wang XW; Johansen JS; Andersen JB
Clin Cancer Res; 2020 Nov; 26(21):5655-5667. PubMed ID: 32933994
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.
Ma C; Zhang Q; Ye J; Wang F; Zhang Y; Wevers E; Schwartz T; Hunborg P; Varvares MA; Hoft DF; Hsueh EC; Peng G
J Immunol; 2012 Nov; 189(10):5029-36. PubMed ID: 23034170
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer.
Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Bojesen SE; Pfeiffer P; Bjerregaard JK; Nielsen SE; Andersen F; Holländer NH; Yilmaz MK; Rasmussen LS; Johansen JS
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):176-184. PubMed ID: 31685562
[TBL] [Abstract][Full Text] [Related]
13. Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.
Sa-Nguanraksa D; Suntiparpluacha M; Kulprom A; Kummalue T; Chuangsuwanich T; Avirutnan P; O-Charoenrat P
Asian Pac J Cancer Prev; 2016; 17(6):2935-40. PubMed ID: 27356714
[TBL] [Abstract][Full Text] [Related]
14. Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression.
Tsukamoto H; Fujieda K; Hirayama M; Ikeda T; Yuno A; Matsumura K; Fukuma D; Araki K; Mizuta H; Nakayama H; Senju S; Nishimura Y
Cancer Res; 2017 May; 77(9):2279-2291. PubMed ID: 28235765
[TBL] [Abstract][Full Text] [Related]
15. Rapid monocyte infiltration following retinal detachment is dependent on non-canonical IL6 signaling through gp130.
Wang X; Miller EB; Goswami M; Zhang P; Ronning KE; Karlen SJ; Zawadzki RJ; Pugh EN; Burns ME
J Neuroinflammation; 2017 Jun; 14(1):121. PubMed ID: 28645275
[TBL] [Abstract][Full Text] [Related]
16. Serum IL-6 and IL-12 levels in breast cancer patients.
Hussein MZ; Al Fikky A; Abdel Bar I; Attia O
Egypt J Immunol; 2004; 11(2):165-70. PubMed ID: 16734129
[TBL] [Abstract][Full Text] [Related]
17. SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells.
Gopalakrishnan S; Uma SK; Mohan G; Mohan A; Shanmugam G; Kumar VTV; J S; Chandrika SK; Vasudevan D; Nori SRC; Sathi SN; George S; Maliekal TT
Front Immunol; 2021; 12():740620. PubMed ID: 34867962
[TBL] [Abstract][Full Text] [Related]
18. Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.
Levin LI; Breen EC; Birmann BM; Batista JL; Magpantay LI; Li Y; Ambinder RF; Mueller NE; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1114-1123. PubMed ID: 28341757
[No Abstract] [Full Text] [Related]
19. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
Caetano MS; Zhang H; Cumpian AM; Gong L; Unver N; Ostrin EJ; Daliri S; Chang SH; Ochoa CE; Hanash S; Behrens C; Wistuba II; Sternberg C; Kadara H; Ferreira CG; Watowich SS; Moghaddam SJ
Cancer Res; 2016 Jun; 76(11):3189-99. PubMed ID: 27197187
[TBL] [Abstract][Full Text] [Related]
20. An autoantibody against a 48-Kd fragment of human DNA-topoiomerase I in breast cancer: Implication for diagnosis and prognosis, and antibody-dependent cellular cytotoxicity in vitro.
He X; Jiang XH; Yie KY; Chen J; Zhang JB; Yie SM
Cell Immunol; 2020 Jan; 347():104007. PubMed ID: 31732123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
